Answer:
The correct answer is Understanding the enzyme's structure would help pharmaceutical companies design molecules that fit to the binding site and alter activity.
Explanation:
Enzymes are "specialist" proteins and control all of our body's chemical reactions. There are enzymes in everything that is alive. They are said to be catalysts, because each chemical reaction needs an enzyme to be carried out, that is, everything that is transformed is done thanks to an enzyme. Each enzyme acts on a specific substance, like a key and a lock.
Drugs work by causing changes in some physiological process or function. Many exert their effect by specifically interacting with some macromolecular structure in the body. To refer to this macromolecule, Paul Erlich He proposed the term "receiver" at the beginning of the last century. In this way, the interaction of each drug with its respective receptor or site of action initiates the biochemical and physiological changes that are characteristic of that drug.
An example of a site of action is that of enzymes, proteins specialized in accelerating biochemical reactions. The interaction of a drug with its molecular target has been compared very simply with what happens between a key and a lock. In this case, the key fits into the lock to produce an action: open or close that lock.
Answer:
d. 8.18 million
MVA is $380 million
Explanation:
Net residual Income is the value of the firm. All the preferred and required / agreed return on any the funding availed is deducted from the net earning after profit to make the value for the firm. The income purely associated to the firm is considered as the value of the firm.
Earning Before Interest and tax = Net Sales - Operating costs = $80 million - $52 million = $28 million
Net Operating profit after tax = $28 x ( 1 - 40% ) = $16.8 million
Return on investor-supplied capital = $115 million x 7.5% = $8.625 million
Value created for the firm = Net operating profit after tax - Return on investor-supplied capital = $16.8 - $8.625 = $8.175 million = $8.18 million
MVA is the net of market capitalization and stockholders equity of the firm. It is the difference of market value and book value of equity of a firm.
MVA = ( Outstanding shares x Market value of shares ) - Book value od the equity = ( 20 million shares x $25 per share ) - $120 million = $500 million - $120 million = $380 million
Answer: 64.47%
Explanation:
Units produced in October = 17470
Units production in the most efficient way = 27,100
Therefore, the capacity utilization rate in October for the factory will be:
= Units produced in October / Units production in the most efficient way
= 17470 / 27100
= 0.6447
= 64.47%
The capacity utilization rate in October for this factory is 64.47%.
When the price of foreign inputs falls, the U.S. SRAS curve option (b)i.e, shifts rightward; which tends to reduce the U.S. price level.
<h3>
What is the SRAS curve?</h3>
We can understand how each firm in an economy reacts to price stickiness using the short-run aggregate supply curve (SRAS). The SRAS curve will have an upward slope when prices are stable. According to the SRAS curve, more output results from higher price levels.
The cost of labor, or wages, and the price of imported commodities that we use as inputs for other products are two other significant variables that may cause the SRAS curve to change in addition to energy prices.
A higher level of productivity causes the SRAS curve to move to the right because businesses can produce more output at all price points.
To know more about SRAS curve refer to: brainly.com/question/16909327
#SPJ4
